IMMUNIC director Michael Bonney files Form 3

IMMUNIC, INC. filed an initial insider ownership report for director Michael W. Bonney on Form 3.

Rhea-AI Filing Summary

IMMUNIC, INC. filed an initial insider ownership report for director Michael W. Bonney on Form 3. This filing identifies him as a director of the company but does not list any stock or option transactions, and shows no reported holdings or derivative positions at this time.

Key Terms

Form 3, director, ten percent owner, reporting person

4 terms

Form 3 regulatory

"filed an initial insider ownership report for director Michael W. Bonney on Form 3"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

director financial

"identifies him as a director of the company but does not list any stock"

ten percent owner regulatory

"the field for ten percent owner is marked negative"

reporting person regulatory

"registers him as a reporting person under Section 16"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the IMMUNIC (IMUX) Form 3 filing for Michael W. Bonney show?

The Form 3 for IMMUNIC director Michael W. Bonney is an initial ownership statement. It lists him as a director but reports no stock, option transactions, or derivative positions, and shows no current holdings in IMMUNIC common equity in this filing.

Did Michael W. Bonney buy or sell IMUX shares in this Form 3?

No, the Form 3 for IMMUNIC director Michael W. Bonney reports no buy or sell transactions. All transaction counts and share totals in the filing’s transaction summary are zero, indicating only an initial registration as a reporting insider.

Does the IMMUNIC (IMUX) Form 3 indicate any derivative securities for Michael W. Bonney?

No, the Form 3 shows no derivative securities for Michael W. Bonney. The derivative summary is empty and the exercise and derivative transaction counts in the transaction summary are zero, indicating no options, warrants, or similar instruments are reported here.

Is Michael W. Bonney a ten percent owner of IMMUNIC (IMUX) according to this Form 3?

According to the Form 3, Michael W. Bonney is listed as a director and not as a ten percent owner. The field for ten percent owner is marked negative, so the filing does not identify him as holding at least ten percent of IMMUNIC’s equity.

Why is IMMUNIC (IMUX) filing a Form 3 for Michael W. Bonney?

Form 3 is required when someone becomes an insider such as a director. IMMUNIC’s filing for Michael W. Bonney formally registers him as a reporting person under Section 16, even though it shows no transactions or current holdings in this particular filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/19/2026 - 05:36 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

BONNEY MICHAEL W

(Last) (First) (Middle)

1200 AVENUE OF THE AMERICAS, SUITE 200

(Street)

NEW YORK NEW YORK 10036

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/16/2026

3. Issuer Name and Ticker or Trading Symbol
IMMUNIC, INC. [ IMUX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

No securities are beneficially owned.

No securities are beneficially owned.

	/s/ Grant Levine, attorney-in-fact	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)